0001654954-23-002834.txt : 20230413 0001654954-23-002834.hdr.sgml : 20230413 20230314153255 ACCESSION NUMBER: 0001654954-23-002834 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dermata Therapeutics, Inc. CENTRAL INDEX KEY: 0001853816 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3525 DEL MAR HEIGHTS RD., #322 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858)-223-0882 MAIL ADDRESS: STREET 1: 3525 DEL MAR HEIGHTS RD., #322 CITY: SAN DIEGO STATE: CA ZIP: 92130 CORRESP 1 filename1.htm drma-accelerationrequestw
 
 
March 14, 2023
 
VIA EDGAR
 
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
 
 
Re:
Dermata Therapeutics, Inc.
Registration Statement on Form S-1, as amended
File No. 333-270195  

Ladies and Gentlemen:
 
Reference is made to our letter, filed as correspondence via EDGAR on March 13, 2023, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for Tuesday, March 14, 2023, at 1:00 p.m., Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
 
Please call Steven M. Skolnick of Lowenstein Sandler LLP at (646) 414-6947 with any questions.
 
 
 
Sincerely,
 
 
 
DERMATA THERAPEUTICS INC.
 
 
 
By:
/s/ Gerald T. Proehl
 
Name:
Gerald T. Proehl
 
Title:
Chief Executive Officer